Close Menu
Entebbe News
    Facebook X (Twitter) Instagram
    Entebbe NewsEntebbe News
    Facebook X (Twitter) Instagram
    • Home
    • Politics
    • Reviews
    • Sports
    • Tech
    • Travel
    • Business
    • Entertainment
    • Events
    • Gossip
    • Relationships
    • Advertise
    Entebbe News
    Home»Health»Covidex Clinical Trial Results Expected in May 2022
    Health

    Covidex Clinical Trial Results Expected in May 2022

    ANGECIESBy ANGECIESJanuary 1, 2022Updated:January 1, 2022No Comments2 Mins Read
    Facebook Twitter WhatsApp Telegram LinkedIn Email
    Covidex Clinical Trial Results Expected in May 2022
    Share
    Facebook Twitter WhatsApp LinkedIn Email Telegram

    President Museveni announced that clinical trial results of COVIDEX will come out in May, 2022, noting that the medicine is currently being tried in a clinical setting.

    While addressing the Nation on New Year’s Eve, Friday, Museveni said he has interviewed many COVID-19 patients who have been cured by herbal remedies.

    “Ugandan scientists and the community, the latter through their ancient knowledge of the environment, have discovered substances that seem to cure corona and other viral diseases. I have interviewed many patients, that have been cured,” he said.

    Adding: “Dr Patrick Ogwang is now trying out the medicine in a clinical setting. We shall know the results of this clinical trial by May, 2022. This would be a path finder, in terms of medical care.”

    free unlimited internet installation uganda by black knight africa

    Prof. Patrick Ogwang is the inventor of COVIDEX, a drug that has been adopted by many in the management of COVID-19.

    He also owns Jena Herbals (U) Ltd, a company that manufactures COVIDEX.

    Meanwhile, Museveni said that up to today, the total vaccine doses administered are 11,377,067 and out of this, 3,756,248 million people have been vaccinated fully either with 2 dozes of the various vaccine types or the one vaccine of Johnson and Johnson.

    Of the 22 million people (priority population for lifting lockdown), Museveni said, 45% (9,979,206) of the target population, have received at least one shot of the vaccine and 17% have been fully vaccinated.

    “As of today, we have received a total of 20,658,940 million vaccine types that need two dozes to cover one person and 12,037,500 million of the single doze Johnson and Johnson. This means that we have already used 21,086,318 and what we have but have not used, have the capacity to vaccinate 8,503,631 million people or to cover 6.1million people due for second dose,” he said.

    “We are expecting another 7,319,610 million double doze vaccines, able to vaccinate 3,659,805million people and another 3,691,200 Johnson and Johnson able to vaccinate a similar number,” he added.

    Digital Marketing Agency - Host256
    Digital Marketing Agency - Host256
    Clinical Trial COVID-19 Covidex
    Share. Facebook Twitter WhatsApp Telegram Email LinkedIn
    ANGECIES
    • Website

    Related Posts

    Standard Chartered Uganda Reaffirms Long‑Term Commitment to Uganda-Strengthens Governance and Deepens Support for National Growth

    May 13, 2026

    37 evacuated to hospital, phones snatched at Museveni’s inauguration ceremony

    May 13, 2026

    Anita Among Faces Formal Complaint at Inspectorate of Government Over Leadership Code Act Breach

    May 13, 2026
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Entebbe News
    Facebook X (Twitter) Instagram WhatsApp
    © 2026 Entebbe News.

    Type above and press Enter to search. Press Esc to cancel.